Research Paper Volume 11, Issue 9 pp 2874—2888
Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients
Figure 5. Relationship between the baseline (w0) and the follow-up (w24 minus w0) levels of circulating Hcy and the ability of treatment arms to achieve pCR. (w: week).